 | • レポートコード：QYR9ST06077 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、イブルチニブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、90カプセル/箱、120カプセル/箱に、用途別には、マントル細胞リンパ腫、慢性リンパ性白血病、小リンパ球性リンパ腫、その他にセグメント区分し、イブルチニブの世界市場を分析しました。 ・エグゼクティブ・サマリー ・イブルチニブの世界市場概要 ・イブルチニブの製造コスト構成分析 ・イブルチニブの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・イブルチニブの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・イブルチニブのセグメント分析（種類別） （90カプセル/箱、120カプセル/箱） ・イブルチニブのセグメント分析（用途別） （マントル細胞リンパ腫、慢性リンパ性白血病、小リンパ球性リンパ腫、その他） ・イブルチニブの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Beacon Pharmaceuticals、Janssen Pharmaceuticals、Incepta Pharmaceuticals、Pharmacyclics Inc、Bluepharma、Johnson & Johnson） ・イブルチニブの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Ibrutinib market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ibrutinib volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ibrutinib market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ibrutinib in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ibrutinib manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Beacon Pharmaceuticals
Janssen Pharmaceuticals
Incepta Pharmaceuticals
Pharmacyclics Inc
Bluepharma
Johnson & Johnson
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
90 Capsules/Box
120 Capsules/Box
Segment by Application
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Other
Table of Contents
Executive Summary
1 Industry Overview of Ibrutinib
1.1 Definition of Ibrutinib
1.2 Ibrutinib Segment by Type
1.2.1 Global Ibrutinib Production Growth Rate Comparison by Types (2014-2025)
1.2.2 90 Capsules/Box
1.2.3 120 Capsules/Box
1.3 Ibrutinib Segment by Applications
1.3.1 Global Ibrutinib Consumption Comparison by Applications (2014-2025)
1.3.2 Mantle Cell Lymphoma
1.3.3 Chronic Lymphocytic Leukemia
1.3.4 Small Lymphocytic Lymphoma
1.3.5 Other
1.4 Global Ibrutinib Overall Market
1.4.1 Global Ibrutinib Revenue (2014-2025)
1.4.2 Global Ibrutinib Production (2014-2025)
1.4.3 North America Ibrutinib Status and Prospect (2014-2025)
1.4.4 Europe Ibrutinib Status and Prospect (2014-2025)
1.4.5 China Ibrutinib Status and Prospect (2014-2025)
1.4.6 Japan Ibrutinib Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ibrutinib Status and Prospect (2014-2025)
1.4.8 India Ibrutinib Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ibrutinib
2.3 Manufacturing Process Analysis of Ibrutinib
2.4 Industry Chain Structure of Ibrutinib
3 Development and Manufacturing Plants Analysis of Ibrutinib
3.1 Capacity and Commercial Production Date
3.2 Global Ibrutinib Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ibrutinib
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Ibrutinib Production and Capacity Analysis
4.2 Ibrutinib Revenue Analysis
4.3 Ibrutinib Price Analysis
4.4 Market Concentration Degree
5 Ibrutinib Regional Market Analysis
5.1 Ibrutinib Production by Regions
5.1.1 Global Ibrutinib Production by Regions
5.1.2 Global Ibrutinib Revenue by Regions
5.2 Ibrutinib Consumption by Regions
5.3 North America Ibrutinib Market Analysis
5.3.1 North America Ibrutinib Production
5.3.2 North America Ibrutinib Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ibrutinib Import and Export
5.4 Europe Ibrutinib Market Analysis
5.4.1 Europe Ibrutinib Production
5.4.2 Europe Ibrutinib Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ibrutinib Import and Export
5.5 China Ibrutinib Market Analysis
5.5.1 China Ibrutinib Production
5.5.2 China Ibrutinib Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ibrutinib Import and Export
5.6 Japan Ibrutinib Market Analysis
5.6.1 Japan Ibrutinib Production
5.6.2 Japan Ibrutinib Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ibrutinib Import and Export
5.7 Southeast Asia Ibrutinib Market Analysis
5.7.1 Southeast Asia Ibrutinib Production
5.7.2 Southeast Asia Ibrutinib Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ibrutinib Import and Export
5.8 India Ibrutinib Market Analysis
5.8.1 India Ibrutinib Production
5.8.2 India Ibrutinib Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ibrutinib Import and Export
6 Ibrutinib Segment Market Analysis (by Type)
6.1 Global Ibrutinib Production by Type
6.2 Global Ibrutinib Revenue by Type
6.3 Ibrutinib Price by Type
7 Ibrutinib Segment Market Analysis (by Application)
7.1 Global Ibrutinib Consumption by Application
7.2 Global Ibrutinib Consumption Market Share by Application (2014-2019)
8 Ibrutinib Major Manufacturers Analysis
8.1 Beacon Pharmaceuticals
8.1.1 Beacon Pharmaceuticals Ibrutinib Production Sites and Area Served
8.1.2 Beacon Pharmaceuticals Product Introduction, Application and Specification
8.1.3 Beacon Pharmaceuticals Ibrutinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Janssen Pharmaceuticals
8.2.1 Janssen Pharmaceuticals Ibrutinib Production Sites and Area Served
8.2.2 Janssen Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Janssen Pharmaceuticals Ibrutinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Incepta Pharmaceuticals
8.3.1 Incepta Pharmaceuticals Ibrutinib Production Sites and Area Served
8.3.2 Incepta Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Incepta Pharmaceuticals Ibrutinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pharmacyclics Inc
8.4.1 Pharmacyclics Inc Ibrutinib Production Sites and Area Served
8.4.2 Pharmacyclics Inc Product Introduction, Application and Specification
8.4.3 Pharmacyclics Inc Ibrutinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bluepharma
8.5.1 Bluepharma Ibrutinib Production Sites and Area Served
8.5.2 Bluepharma Product Introduction, Application and Specification
8.5.3 Bluepharma Ibrutinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Ibrutinib Production Sites and Area Served
8.6.2 Johnson & Johnson Product Introduction, Application and Specification
8.6.3 Johnson & Johnson Ibrutinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
9 Development Trend of Analysis of Ibrutinib Market
9.1 Global Ibrutinib Market Trend Analysis
9.1.1 Global Ibrutinib Market Size (Volume and Value) Forecast 2019-2025
9.2 Ibrutinib Regional Market Trend
9.2.1 North America Ibrutinib Forecast 2019-2025
9.2.2 Europe Ibrutinib Forecast 2019-2025
9.2.3 China Ibrutinib Forecast 2019-2025
9.2.4 Japan Ibrutinib Forecast 2019-2025
9.2.5 Southeast Asia Ibrutinib Forecast 2019-2025
9.2.6 India Ibrutinib Forecast 2019-2025
9.3 Ibrutinib Market Trend (Product Type)
9.4 Ibrutinib Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Ibrutinib Distributors List
10.3 Ibrutinib Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Ibrutinib
Table Global Ibrutinib Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Ibrutinib Production Market Share by Types in 2018
Figure 90 Capsules/Box Product Picture
Figure 120 Capsules/Box Product Picture
Table Global Ibrutinib Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Ibrutinib Consumption Market Share by Applications in 2018
Figure Mantle Cell Lymphoma
Figure Chronic Lymphocytic Leukemia
Figure Small Lymphocytic Lymphoma
Figure Other
Figure Global Ibrutinib Revenue (Million USD) (2014-2025)
Figure Global Ibrutinib Production (K Pcs) (2014-2025)
Figure North America Ibrutinib Market Size (Million USD) (2014-2025)
Figure Europe Ibrutinib Market Size (Million USD) (2014-2025)
Figure China Ibrutinib Market Size (Million USD) (2014-2025)
Figure Japan Ibrutinib Market Size (Million USD) (2014-2025)
Figure Southeast Asia Ibrutinib Market Size (Million USD) (2014-2025)
Figure India Ibrutinib Market Size (Million USD) (2014-2025)
Table Ibrutinib Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ibrutinib in 2018
Figure Manufacturing Process Analysis of Ibrutinib
Figure Industry Chain Structure of Ibrutinib
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Ibrutinib Manufacturing Plants Distribution
Table Ibrutinib Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Ibrutinib Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Ibrutinib Production (K Pcs) of Major Manufacturers (2014-2019)
Table Ibrutinib Production Market Share of Major Manufacturers (2014-2019)
Figure Ibrutinib Production Share by Manufacturers in 2018
Table Ibrutinib Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Ibrutinib Revenue Market Share of Major Manufacturers (2014-2019)
Figure Ibrutinib Revenue Share by Manufacturers in 2018
Table Ibrutinib Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Ibrutinib Production by Regions 2014-2019 (K Pcs)
Table Global Ibrutinib Production Market Share by Regions 2014-2019
Figure Global Ibrutinib Production Market Share by Regions in 2018
Table Global Ibrutinib Revenue by Regions 2014-2019 (Million USD)
Table Global Ibrutinib Revenue Market Share by Regions 2014-2019
Figure Global Ibrutinib Revenue Market Share by Regions in 2018
Table Global Ibrutinib Consumption by Regions 2014-2019 (K Pcs)
Table Global Ibrutinib Consumption Market Share by Regions 2014-2019
Figure North America Ibrutinib Production Growth Rate 2014-2019 (K Pcs)
Figure North America Ibrutinib Revenue Growth Rate 2014-2019 (Million USD)
Table North America Ibrutinib Production, Consumption Import and Export (K Pcs)
Figure Europe Ibrutinib Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Ibrutinib Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Ibrutinib Production, Consumption Import and Export (K Pcs)
Figure China Ibrutinib Production Growth Rate 2014-2019 (K Pcs)
Figure China Ibrutinib Revenue Growth Rate 2014-2019 (Million USD)
Table China Ibrutinib Production, Consumption Import and Export (K Pcs)
Figure Japan Ibrutinib Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Ibrutinib Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Ibrutinib Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Ibrutinib Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Ibrutinib Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Ibrutinib Production, Consumption Import and Export (K Pcs)
Figure India Ibrutinib Production Growth Rate 2014-2019 (K Pcs)
Figure India Ibrutinib Revenue Growth Rate 2014-2019 (Million USD)
Table India Ibrutinib Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Ibrutinib Market Share by Application (2014-2019)
Figure Global Value (Consumption) Ibrutinib Market Share by Application (2014-2019)
Table Beacon Pharmaceuticals Ibrutinib Production Sites and Area Served
Table Beacon Pharmaceuticals Ibrutinib Product Introduction, Application and Specification
Table Beacon Pharmaceuticals Ibrutinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Beacon Pharmaceuticals Ibrutinib Production Growth Rate (2014-2019)
Table Beacon Pharmaceuticals Ibrutinib Production Market Share (2014-2019)
Figure Beacon Pharmaceuticals Ibrutinib Revenue Market Share (2014-2019)
Table Beacon Pharmaceuticals Ibrutinib Main Business and Markets Served
Table Janssen Pharmaceuticals Ibrutinib Production Sites and Area Served
Table Janssen Pharmaceuticals Ibrutinib Product Introduction, Application and Specification
Table Janssen Pharmaceuticals Ibrutinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Janssen Pharmaceuticals Ibrutinib Production Growth Rate (2014-2019)
Table Janssen Pharmaceuticals Ibrutinib Production Market Share (2014-2019)
Figure Janssen Pharmaceuticals Ibrutinib Revenue Market Share (2014-2019)
Table Janssen Pharmaceuticals Ibrutinib Main Business and Markets Served
Table Incepta Pharmaceuticals Ibrutinib Production Sites and Area Served
Table Incepta Pharmaceuticals Ibrutinib Product Introduction, Application and Specification
Table Incepta Pharmaceuticals Ibrutinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Incepta Pharmaceuticals Ibrutinib Production Growth Rate (2014-2019)
Table Incepta Pharmaceuticals Ibrutinib Production Market Share (2014-2019)
Figure Incepta Pharmaceuticals Ibrutinib Revenue Market Share (2014-2019)
Table Incepta Pharmaceuticals Ibrutinib Main Business and Markets Served
Table Pharmacyclics Inc Ibrutinib Production Sites and Area Served
Table Pharmacyclics Inc Ibrutinib Product Introduction, Application and Specification
Table Pharmacyclics Inc Ibrutinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pharmacyclics Inc Ibrutinib Production Growth Rate (2014-2019)
Table Pharmacyclics Inc Ibrutinib Production Market Share (2014-2019)
Figure Pharmacyclics Inc Ibrutinib Revenue Market Share (2014-2019)
Table Pharmacyclics Inc Ibrutinib Main Business and Markets Served
Table Bluepharma Ibrutinib Production Sites and Area Served
Table Bluepharma Ibrutinib Product Introduction, Application and Specification
Table Bluepharma Ibrutinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bluepharma Ibrutinib Production Growth Rate (2014-2019)
Table Bluepharma Ibrutinib Production Market Share (2014-2019)
Figure Bluepharma Ibrutinib Revenue Market Share (2014-2019)
Table Bluepharma Ibrutinib Main Business and Markets Served
Table Johnson & Johnson Ibrutinib Production Sites and Area Served
Table Johnson & Johnson Ibrutinib Product Introduction, Application and Specification
Table Johnson & Johnson Ibrutinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Ibrutinib Production Growth Rate (2014-2019)
Table Johnson & Johnson Ibrutinib Production Market Share (2014-2019)
Figure Johnson & Johnson Ibrutinib Revenue Market Share (2014-2019)
Table Johnson & Johnson Ibrutinib Main Business and Markets Served
Figure Global Ibrutinib Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Ibrutinib Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Ibrutinib Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Ibrutinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Ibrutinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Ibrutinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Ibrutinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Ibrutinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Ibrutinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Ibrutinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Ibrutinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Ibrutinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Ibrutinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Ibrutinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Ibrutinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Ibrutinib by Type (2019-2025)
Table Global Consumption (K Pcs) of Ibrutinib by Application (2019-2025)
Table Ibrutinib Distributors List
Table Ibrutinib Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のイブルチニブ市場：専門的調査 The global Ibrutinib market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Ibrutinib volume and value at global level, regional level and company level. From a global perspective, this report re…- 急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場：市場規模・現状・予測 Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that quickly progresses and spreads across the body.ALL develops in bone marrow and quickly invades other parts of the body including the liver, spleen, lymph n…
- 急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場：市場規模・現状・予測 Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that quickly progresses and spreads across the body.ALL develops in bone marrow and quickly invades other parts of the body including the liver, spleen, lymph n…
- ホジキンリンパ腫治療の世界市場：市場規模・現状・予測 Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- バーキットリンパ腫治療の世界市場：市場規模・現状・予測 Burn is an injury to skin or any tissue of body due to excessive heat, radiation, radioactivity, electricity, or contact with chemical materials. Burns are a serious problem across the globe and the World Health Organization estimates that it results in more than 265,000 deaths occur annually. Moreo…